Clinical Trial Update: Arimoclomol Prospective Study in Participants Diagnosed With Niemann-Pick Disease Type C [Phase 2, Phase 3]

View source ↗

Summary

A prospective Phase 2/3 trial of arimoclomol in Niemann-Pick Disease Type C has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Niemann-pick Disease Type

Drugs mentioned

• Arimoclomol (arimoclomol)

Snippet

Sponsor: ZevraDenmark | Conditions: Niemann-Pick Disease, Type C | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2023-06-09